Sign In

Paul Peloso

Chief Medical Officer at ACELYRIN, INC.

Professional Background

Paul Peloso is an accomplished medical professional with over 13 years of extensive experience in the pharmaceutical industry, specializing in every phase of drug development. His expertise spans from the initial stages of Phase 1 trials to conducting dose-ranging and registrational trials, as well as post-market studies. His comprehensive knowledge and experience have made him a sought-after expert in clinical development and regulatory affairs.

Currently, Paul serves as the Chief Medical Officer at ACELYRIN, INC., where he leads efforts to innovate and enhance therapeutic solutions. Prior to this role, he was the Vice President and Therapeutic Area Head of Rheumatology at Horizon Pharma plc, where he significantly contributed to the development and advancement of therapies in rheumatology. Previously, he held the prestigious position of Group Medical Director - Clinical Development at AbbVie, where his strategic insight and leadership greatly impacted the company's clinical trial programs.

Paul has also made significant contributions to clinical research while serving as the Executive Director of Clinical Research at Merck, where he led various initiatives that helped optimize clinical trial success rates. His outstanding leadership and direction throughout his career have resulted in successful drug filings across multiple therapeutic areas worldwide, including submissions with regulatory agencies such as the FDA, EMA, as well as regulatory bodies in Asia and Latin America.

Education and Achievements

Paul Peloso possesses a robust educational background that underlines his expertise in clinical epidemiology, internal medicine, and rheumatology. He began his academic journey with a Bachelor of Arts in Sociology and a Bachelor of Science in Chemistry from McMaster University. This dual foundation allowed him to develop a well-rounded perspective on both the humanities and biological sciences.

He further pursued a Doctor of Medicine (MD) degree from the University of Calgary, where he also completed his FRCPC in Internal Medicine and Rheumatology. His Master of Science in Clinical Epidemiology, obtained from the University of Toronto, has equipped him with the skills to analyze clinical data rigorously and apply principles of epidemiology to drug development and population health.

Throughout his career, Paul has been instrumental in launching several successful drug candidates and has collaborated effectively with global regulatory agencies to ensure compliance and drive innovation in drug development. His myriad of experiences has culminated in a wealth of knowledge in navigating the often-complex landscape of drug regulation and approval.

Notable Achievements and Contributions

Paul Peloso's career has been marked by significant achievements in clinical research and drug development. His roles across various esteemed organizations highlight his capacity to lead and inspire medical teams toward achieving clinical excellence.

  • Successful Regulatory Filings: Paul has been pivotal in securing successful regulatory filings for several drugs across diverse therapeutic areas. His work has enabled numerous treatments to reach patients, improving their quality of life and health outcomes.
  • Global Regulatory Experience: With extensive experience working with regulatory agencies, including the FDA, EMA, and other national agencies across Asia and Latin America, Paul has a unique understanding of global health regulations and practices. This insight has proven valuable in various strategic meetings and negotiations concerning drug approval processes.
  • Leadership Roles: His leadership roles in well-respected organizations demonstrate a track record of effectively guiding teams through the intricate processes of clinical trials and drug approvals. His ability to formulate strategies that align with organizational objectives has been a key aspect of his success.

In summary, Paul Peloso brings a wealth of knowledge, skill, and experience to his role in the pharmaceutical industry. His dedication to advancing therapeutic solutions for patients, coupled with his impressive background in clinical trials, regulatory affairs, and leadership, makes him a notable figure in the field of drug development.

Related Questions

How did Paul Peloso develop his expertise in drug development and clinical research?
What are some of the most significant drug candidates Paul Peloso has worked on during his career?
How has Paul Peloso's education in clinical epidemiology influenced his approach to drug development?
In what ways has Paul Peloso collaborated with global regulatory agencies to enhance drug approvals?
What leadership strategies does Paul Peloso employ to guide his teams in clinical research?
Paul Peloso
Add to my network

Location

Greater Chicago Area